NCT00881205 - Rivastigmine in Multiple Sclerosis Patients With Cognitive Impairment | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions

Multiple SclerosisCognitive Impairment

Interventions

DRUG

Rivastigmine transdermal patch

Transdermalapplication of one 5 cm² patch, followed by an increase to the target dose of 10 cm² patch size. All patches are round, beige in color.

DRUG

Placebo

Transdermal application of one 5 cm² patch, followed by an increase to the target dose of 10 cm² patch size. Matching the size, shape and color of rivastigmine patches.

Trial Locations (49)

10178

Novartis Investigative Site, Berlin

10713

Novartis Investigative SIte, Berlin

12103

Novartis Investigative Site, Berlin

13347

Novartis Investigative Site, Berlin

18147

Novartis Investigative Site, Rostock

20354

Novartis Investigative Site, Hamburg

21335

Novartis Investigative Site, Lüneburg

21682

Novartis Investigative Site, Stade

22083

Novartis Investigative Site, Hamburg

22179

Novartis Investigational Site, Hamburg

24568

Novartis Investigative Site, Kaltenkirchen

25524

Novartis Investigative Site, Itzehoe

26122

Novartis Investigative Site, Oldenburg

28832

Novartis Investigative Site, Achim

30623

Novartis Investigative Site, Hanover

35385

Novartis Investigative Site, Giessen

37075

Novartis Investigative Site, Göttingen

40211

Novartis Investigative Site, Düsseldorf

44892

Novartis Investigative Site, Bochum

45122

Novartis Investigative Site, Essen

45138

Novartis Investigative Site, Essen

47798

Novartis Investigative Site, Krefeld

49078

Novartis Investigative Site, Osnabrück

51109

Novartis Investigative Site, Cologne

52062

Novartis Investigative Site, Aachen

63739

Novartis Investigative Site, Aschaffenburg

63755

Novartis Investigative Site, Alzenau in Unterfranken

64711

Novartis Investigative Site, Erbach im Odenwald

65183

Novartis Investigative Site, Wiesbaden

67059

Novartis Investigative Site, Ludwigshafen

69518

Novartis Investigative Site, Viernheim

70182

Novartis Investigative Site, Stuttgart

70191

Novartis Investigative Site, Stuttgart

71034

Novartis Investigative Site, Böblingen

73430

Novartis Investigative Site, Aalen

73479

Novartis Investigative Site, Ellwangen

82008

Novartis Investigative Site, Unterhaching

82515

Novartis Investigative Site, Wolfratshausen

86633

Novartis Investigative Site, Neuburg am Inn

89073

Novartis Investigative Site, Ulm

89231

Novartis Investigative Site, Neu-Ulm

91054

Novartis Investigative Site, Erlangen

93138

Novartis Investigative Site, Lappersdorf

93326

Novartis Investigative Site, Abensberg

95445

Novartis Investigative Site, Bayreuth

97980

Novartis Investigative Site, Bad Mergentheim

99817

Novartis Investigative Site, Eisenach

04103

Novartis Investigative Site, Leipzig

04157

Novartis Investigative Site, Leipzig